<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1003" relname="span">The development of flow processes has gained tremendous interest in recent years in organic chemistry</segment>
<segment id="3" parent="2" relname="elaboration">due to numerous advantages of such types of processes over classic batch approaches .</segment>
<segment id="4" parent="1004" relname="joint">In addition to higher efficiency and safety advantages ,</segment>
<segment id="5" parent="1005" relname="span">the ability</segment>
<segment id="6" parent="5" relname="purpose">to ensure constant product quality has turned out to be a major driving force for the development of flow processes .</segment>
<segment id="7" parent="1008" relname="span">In particular , for active pharmaceutical ingredients</segment>
<segment id="8" parent="7" relname="elaboration">( APIs ) ,</segment>
<segment id="9" parent="1007" relname="same_unit">this aspect is important ,</segment>
<segment id="10" parent="1010" relname="span">as the FDA along with the EPA , as the respective institutions in United States and Europe for approval of medicines , added aspects of continuous manufacturing to their guidelines ,</segment>
<segment id="11" parent="10" relname="circumstance">whereas for a long time the focus of flow processes was on “ classic ” chemical processes with , for example , hazardous and thermally labile substances and chemocatalytic reactions .</segment>
<segment id="12" parent="1012" relname="preparation">Recently , biocatalysis in flow processes has become an emerging field with an increasing number of examples .</segment>
<segment id="13" parent="1014" relname="preparation">An enzymatic reaction of particular interest for an application in flow mode</segment>
<segment id="14" parent="1015" relname="attribution">due to its matured technology level is asymmetric ketone reduction ,</segment>
<segment id="15" parent="1015" relname="span">having a proven track record</segment>
<segment id="16" parent="1016" relname="span">underlined by many successful examples</segment>
<segment id="17" parent="16" relname="elaboration">demonstrated in the past for the batch mode .</segment>
<segment id="18" parent="1019" relname="span">Recently , significant process in the biocatalytic reductive synthesis of alcohols</segment>
<segment id="19" parent="18" relname="elaboration">starting from ketones , as well as syntheses by non-enzymatic means ,</segment>
<segment id="20" parent="1018" relname="same_unit">have been reported .</segment>
<segment id="21" parent="1020" relname="sequence">In recent years , an increasing number of examples of biocatalysis in flow processes have been reported .</segment>
<segment id="22" parent="1023" relname="span">Although only being studied to a minor extent , some examples of ketone reductions with an alcohol dehydrogenase</segment>
<segment id="23" parent="22" relname="elaboration">( ADH )</segment>
<segment id="24" parent="1022" relname="same_unit">in flow processes have been described .</segment>
<segment id="25" parent="1025" relname="joint">For example , Wandrey ’s and Liese ’s groups studied in detail the application of enzyme membrane reactors for enzymatic ketone reduction in a continuously running mode ,</segment>
<segment id="26" parent="1026" relname="span">and packed bed reactor setups were described by further groups</segment>
<segment id="27" parent="1028" relname="span">using carrier-bound ADH from Lactobacillus brevis</segment>
<segment id="28" parent="27" relname="restatement">( LB-ADH )</segment>
<segment id="29" parent="1027" relname="same_unit">in combination with a mobile aqueous phase , or magnetic nanoparticle-bound ADH .</segment>
<segment id="30" parent="1030" relname="span">In addition , Buehler et al.</segment>
<segment id="31" parent="30" relname="elaboration">investigated intensively the use of ADH in aqueous/organic segmented flow systems .</segment>
<segment id="32" parent="1034" relname="attribution">It was shown</segment>
<segment id="33" parent="1034" relname="joint">that emulsion formation could be eliminated ,</segment>
<segment id="34" parent="1034" relname="joint">and enzymatic mass transfer-limited reactions can be enhanced .</segment>
<segment id="35" parent="1035" relname="joint">Furthermore , different means of stabilization of this reaction system were investigated .</segment>
<segment id="36" parent="1036" relname="span">Very recently , our group published an improved downstream process by means of such a segmented flow process ,</segment>
<segment id="37" parent="36" relname="elaboration">illustrated using two different ADHs and substrates .</segment>
<segment id="38" parent="1039" relname="span">In continuous processes</segment>
<segment id="39" parent="1040" relname="span">using packed bed reactors</segment>
<segment id="40" parent="39" relname="elaboration">( PBR ) ,</segment>
<segment id="41" parent="1038" relname="same_unit">catalyst immobilization is a prerequisite .</segment>
<segment id="42" parent="1042" relname="preparation">Also , downstream processes benefit from immobilization ,</segment>
<segment id="43" parent="1043" relname="joint">as separation of the reaction mixture from the catalyst is easier ,</segment>
<segment id="44" parent="1043" relname="joint">and the catalyst reusability is improved .</segment>
<segment id="45" parent="1044" relname="joint">Moreover , both , operational , as well as storage stability of the catalyst can potentially be significantly increased .</segment>
<segment id="46" parent="1046" relname="joint">However , often a significant loss of enzymatic activity during the immobilization process represents a drawback ,</segment>
<segment id="47" parent="1046" relname="joint">and the reproducible production of immobilized catalyst may be a further challenge .</segment>
<segment id="48" parent="1049" relname="span">Numerous techniques have been developed over the past years ,</segment>
<segment id="49" parent="1050" relname="span">which can be classified in the following three major methods :</segment>
<segment id="50" parent="49" relname="restatement">( a )</segment>
<segment id="51" parent="1053" relname="span">binding to a solid support</segment>
<segment id="52" parent="51" relname="restatement">( carrier ) ,</segment>
<segment id="53" parent="1053" relname="restatement">( b )</segment>
<segment id="54" parent="1055" relname="span">entrapment</segment>
<segment id="55" parent="54" relname="elaboration">( encapsulation )</segment>
<segment id="56" parent="1056" relname="contrast">in polymer networks ,</segment>
<segment id="57" parent="1057" relname="span">or ( c )</segment>
<segment id="58" parent="1059" relname="span">cross-linking in the form of cross-linked enzyme aggregates</segment>
<segment id="59" parent="58" relname="restatement">( CLEAs )</segment>
<segment id="60" parent="1060" relname="span">or cross-linked enzyme crystals</segment>
<segment id="61" parent="60" relname="elaboration">( CLECs ) .</segment>
<segment id="62" parent="1062" relname="preparation">Recently , much progress in the field of enzyme immobilization has been made .</segment>
<segment id="63" parent="1062" relname="sequence">In this work , the option of entrapment of enzymes in polymer networks has been chosen .</segment>
<segment id="64" parent="1064" relname="span">Often for this purpose , organic polymers</segment>
<segment id="65" parent="64" relname="elaboration">containing cavities , sol-gel-processed particles , or membranes are used .</segment>
<segment id="66" parent="1069" relname="span">A special case is the use of superabsorbent polymers</segment>
<segment id="67" parent="66" relname="purpose">to immobilize the entire aqueous phase. .</segment>
<segment id="68" parent="1071" relname="span">In this case , the enzyme is immobilized in its native aqueous environment ,</segment>
<segment id="69" parent="68" relname="elaboration">whereby undesired interactions of protein moieties with the support can be prevented .</segment>
<segment id="70" parent="1073" relname="span">Recently , Gröger et al. applied a method</segment>
<segment id="71" parent="70" relname="elaboration">of immobilizing ADHs with superabsorber efficiently for the synthesis of diols in enantiomerically pure form .</segment>
<segment id="72" parent="1074" relname="span">In this example , the immobilized ADH from Rhodococcus sp . was used in organic solvents without a major loss in activity .</segment>
<segment id="73" parent="1076" relname="span">Advantages of this method is the low cost , the very fast immobilization procedure</segment>
<segment id="74" parent="73" relname="elaboration">( &lt;30 min ) ,</segment>
<segment id="75" parent="1077" relname="span">and the excellent catalyst reusability .</segment>
<segment id="76" parent="1078" relname="span">Challenging , in particular with respect to an application in a fixed bed reactor , might be the gel-like consistency of the hydrogel and mass transfer limitations through phase interfaces in general .</segment>
<segment id="77" parent="1080" relname="span">The absorbent polymer consists of cross-linked polyacrylic acid ,</segment>
<segment id="78" parent="77" relname="elaboration">which was partially neutralized .</segment>
<segment id="79" parent="1081" relname="joint">Proteins can be embedded in this polymer matrix</segment>
<segment id="80" parent="1082" relname="span">and can be bound ,</segment>
<segment id="81" parent="1084" relname="span">for example , by ionic interactions of its acid moieties to ionic amino acid residues of the protein</segment>
<segment id="82" parent="81" relname="elaboration">( see</segment>
<segment id="83" parent="1086" relname="preparation">Figure 1</segment>
<segment id="84" parent="1086" relname="span">A ) .</segment>
<segment id="85" parent="1087" relname="span">Also , hydrogen bridges from non-ionic protein residues with superabsorber functionalities</segment>
<segment id="86" parent="85" relname="elaboration">(</segment>
<segment id="87" parent="1089" relname="preparation">Figure 1</segment>
<segment id="88" parent="1089" relname="contrast">B )</segment>
<segment id="89" parent="1090" relname="span">or entrapment of enzyme in superabsorber-bound water residues</segment>
<segment id="90" parent="89" relname="elaboration">(</segment>
<segment id="91" parent="92" relname="preparation">Figure 1</segment>
<segment id="92" parent="1091" relname="span">C ) can be a possible mode of interaction .</segment>
<segment id="93" parent="1094" relname="span">An</segment>
<segment id="94" parent="1095" relname="span">( R )-enantioselective ADH from Lactobacillus brevis</segment>
<segment id="95" parent="94" relname="elaboration">( LB-ADH )</segment>
<segment id="96" parent="1096" relname="span">has been shown to be a versatile catalyst for the reduction of a variety of ketones ,</segment>
<segment id="97" parent="96" relname="elaboration">ranging from aliphatic ketones to benzylic or propargylic ketones .</segment>
<segment id="98" parent="1097" relname="joint">It can be used as an isolated enzyme or as a whole-cell catalyst .</segment>
<segment id="99" parent="1098" relname="span">In particular , its tolerance towards organic solvents is outstanding .</segment>
<segment id="100" parent="1099" relname="joint">The stability depends on several factors , such as the nature of the buffer or solvent additives .</segment>
<segment id="101" parent="1102" relname="span">In this contribution , the application of a superabsorber-immobilized ADH from L. brevis for an enzymatic reduction of acetophenone</segment>
<segment id="102" parent="101" relname="elaboration">( 1 )</segment>
<segment id="103" parent="1101" relname="same_unit">in a flow process</segment>
<segment id="104" parent="1100" relname="same_unit">is described .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1006" relname="background"/>
<group id="1003" type="span" parent="1002" relname="joint"/>
<group id="1004" type="multinuc" parent="1002" relname="joint"/>
<group id="1005" type="span" parent="1004" relname="joint"/>
<group id="1006" type="span" parent="1001" relname="span"/>
<group id="1007" type="multinuc" parent="1009" relname="preparation"/>
<group id="1008" type="span" parent="1007" relname="same_unit"/>
<group id="1009" type="multinuc" parent="1006" relname="span"/>
<group id="1010" type="span" parent="1009" relname="joint"/>
<group id="1011" type="span" parent="1009" relname="joint"/>
<group id="1012" type="multinuc" parent="1011" relname="span"/>
<group id="1013" type="span" parent="1012" relname="joint"/>
<group id="1014" type="span" parent="1013" relname="span"/>
<group id="1015" type="span" parent="1014" relname="span"/>
<group id="1016" type="span" parent="15" relname="elaboration"/>
<group id="1017" type="span" parent="1012" relname="joint"/>
<group id="1018" type="multinuc" parent="1017" relname="span"/>
<group id="1019" type="span" parent="1018" relname="same_unit"/>
<group id="1020" type="multinuc" parent="1018" relname="elaboration"/>
<group id="1021" type="span" parent="1020" relname="sequence"/>
<group id="1022" type="multinuc" parent="1021" relname="span"/>
<group id="1023" type="span" parent="1022" relname="same_unit"/>
<group id="1024" type="multinuc" parent="1022" relname="elaboration"/>
<group id="1025" type="multinuc" parent="1024" relname="joint"/>
<group id="1026" type="span" parent="1025" relname="joint"/>
<group id="1027" type="multinuc" parent="26" relname="means"/>
<group id="1028" type="span" parent="1027" relname="same_unit"/>
<group id="1029" type="multinuc" parent="1024" relname="joint"/>
<group id="1030" type="span" parent="1029" relname="joint"/>
<group id="1031" type="multinuc" parent="1029" relname="joint"/>
<group id="1032" type="multinuc" parent="1031" relname="joint"/>
<group id="1033" type="span" parent="1032" relname="joint"/>
<group id="1034" type="multinuc" parent="1033" relname="span"/>
<group id="1035" type="multinuc" parent="1032" relname="joint"/>
<group id="1036" type="span" parent="1035" relname="joint"/>
<group id="1037" type="multinuc" parent="1031" relname="joint"/>
<group id="1038" type="multinuc" parent="1037" relname="joint"/>
<group id="1039" type="span" parent="1038" relname="same_unit"/>
<group id="1040" type="span" parent="38" relname="means"/>
<group id="1041" type="span" parent="1037" relname="joint"/>
<group id="1042" type="multinuc" parent="1041" relname="span"/>
<group id="1043" type="multinuc" parent="1042" relname="joint"/>
<group id="1044" type="multinuc" parent="1042" relname="joint"/>
<group id="1045" type="multinuc" parent="1044" relname="joint"/>
<group id="1046" type="multinuc" parent="1045" relname="joint"/>
<group id="1047" type="multinuc" parent="1045" relname="joint"/>
<group id="1048" type="multinuc" parent="1047" relname="joint"/>
<group id="1049" type="span" parent="1048" relname="same_unit"/>
<group id="1050" type="span" parent="48" relname="elaboration"/>
<group id="1051" type="multinuc" parent="1048" relname="same_unit"/>
<group id="1052" type="span" parent="1051" relname="same_unit"/>
<group id="1053" type="span" parent="1052" relname="span"/>
<group id="1054" type="multinuc" parent="1051" relname="same_unit"/>
<group id="1055" type="span" parent="1054" relname="same_unit"/>
<group id="1056" type="multinuc" parent="1054" relname="same_unit"/>
<group id="1057" type="span" parent="1056" relname="contrast"/>
<group id="1058" type="multinuc" parent="57" relname="elaboration"/>
<group id="1059" type="span" parent="1058" relname="contrast"/>
<group id="1060" type="span" parent="1058" relname="contrast"/>
<group id="1061" type="span" parent="1047" relname="joint"/>
<group id="1062" type="multinuc" parent="1061" relname="span"/>
<group id="1063" type="span" parent="1062" relname="sequence"/>
<group id="1064" type="span" parent="1065" relname="preparation"/>
<group id="1065" type="multinuc" parent="1063" relname="span"/>
<group id="1066" type="multinuc" parent="1065" relname="joint"/>
<group id="1067" type="span" parent="1066" relname="joint"/>
<group id="1068" type="span" parent="1067" relname="span"/>
<group id="1069" type="span" parent="1068" relname="span"/>
<group id="1070" type="span" parent="1069" relname="elaboration"/>
<group id="1071" type="span" parent="1070" relname="span"/>
<group id="1072" type="span" parent="1071" relname="elaboration"/>
<group id="1073" type="span" parent="1074" relname="preparation"/>
<group id="1074" type="span" parent="1072" relname="span"/>
<group id="1075" type="multinuc" parent="72" relname="elaboration"/>
<group id="1076" type="span" parent="1075" relname="joint"/>
<group id="1077" type="span" parent="1075" relname="joint"/>
<group id="1078" type="span" parent="75" relname="elaboration"/>
<group id="1079" type="span" parent="76" relname="evidence"/>
<group id="1080" type="span" parent="1079" relname="span"/>
<group id="1081" type="multinuc" parent="1080" relname="elaboration"/>
<group id="1082" type="span" parent="1081" relname="joint"/>
<group id="1083" type="span" parent="80" relname="evidence"/>
<group id="1084" type="span" parent="1083" relname="span"/>
<group id="1085" type="span" parent="1084" relname="evidence"/>
<group id="1086" type="span" parent="1085" relname="span"/>
<group id="1087" type="span" parent="84" relname="elaboration"/>
<group id="1088" type="span" parent="1068" relname="restatement"/>
<group id="1089" type="multinuc" parent="1088" relname="span"/>
<group id="1090" type="span" parent="1089" relname="contrast"/>
<group id="1091" type="span" parent="1066" relname="joint"/>
<group id="1092" type="multinuc" parent="1065" relname="joint"/>
<group id="1093" type="multinuc" parent="1092" relname="joint"/>
<group id="1094" type="span" parent="1093" relname="same_unit"/>
<group id="1095" type="span" parent="93" relname="elaboration"/>
<group id="1096" type="span" parent="1093" relname="same_unit"/>
<group id="1097" type="multinuc" parent="1092" relname="joint"/>
<group id="1098" type="span" parent="1097" relname="joint"/>
<group id="1099" type="multinuc" parent="99" relname="elaboration"/>
<group id="1100" type="multinuc" parent="1099" relname="joint"/>
<group id="1101" type="multinuc" parent="1100" relname="same_unit"/>
<group id="1102" type="span" parent="1101" relname="same_unit"/>
	</body>
</rst>
